Загрузка...
Emerging Signaling Pathways in Hepatocellular Carcinoma
Signaling pathways have become a major source of targets for novel therapies in hepatocellular carcinoma (HCC). Survival benefits achieved with sorafenib, a multikinase inhibitor, are unprecedented and underscore the importance of improving our understanding of how signaling networks interact in tra...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
S. Karger AG
2012
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3747540/ https://ncbi.nlm.nih.gov/pubmed/24159576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000342405 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|